Chemical Structure
Bakuchiol [10309-37-2]
AG-CN2-0495
Overview
- SupplierAdipoGen Life Sciences
- Product NameBakuchiol [10309-37-2]
- Delivery Days Customer10
- CAS Number10309-37-2
- CertificationResearch Use Only
- Estimated Purity>98%
- FormulationLiquid
- Molecular FormulaC18H24O
- Molecular Weight256.4
- Scientific DescriptionAntibiotic. Antimicrobial, anti-inflammatory, anticancer and immunosuppressive compound. Shown to have hepatoprotective and hypoglycemic activity. Apoptosis inducer in cancer cells. Sensitizes cancer cells. Induces cell cycle arrest. Antiviral agent. Inhibited influenza A viral infection and growth through activation of Nrf2. Inhibitor of protein tyrosine phosphatase 1B (PTB1B). Antioxidant. Inhibitor of mitochondrial lipid peroxidation. Inhibitor of inducible nitric oxide synthase (iNOS; NOS II) expression via inactivation of NF-kappaB. DNA polymerase and UDP-glucuronosyltransferase inhibitor. Anti-aging compound with retinol-like effects on gene expression and properties of the skin. Phospholipase A, cyclooxygenase-1 (COX-1) and HIF-1 inhibitor. - Chemical. CAS: 10309-37-2. Formula: C18H24O. MW: 256.4. Isolated from Psoralea corylifolia. Antibiotic. Antimicrobial, anti-inflammatory, anticancer and immunosuppressive compound. Shown to have hepatoprotective and hypoglycemic activity. Apoptosis inducer in cancer cells. Sensitizes cancer cells. Induces cell cycle arrest. Antiviral agent. Inhibited influenza A viral infection and growth through activation of Nrf2. Inhibitor of protein tyrosine phosphatase 1B (PTB1B). Antioxidant. Inhibitor of mitochondrial lipid peroxidation. Inhibitor of inducible nitric oxide synthase (iNOS; NOS II) expression via inactivation of NF-kappaB. DNA polymerase and UDP-glucuronosyltransferase inhibitor. Anti-aging compound with retinol-like effects on gene expression and properties of the skin. Phospholipase A, cyclooxygenase-1 (COX-1) and HIF-1 inhibitor.
- SMILESOC1=CC=C(/C=C/[C@](C)(C=C)CC/C=C(C)/C)C=C1
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352200
References
- DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia: N.J. Sun, et al.; J. Nat. Prod. 61, 362 (1998)
- Isolation and antihyperglycemic activity of bakuchiol from Otholobium pubescens (Fabaceae), a Peruvian medicinal plant used for the treatment of diabetes: J.M. Krenisky, et al.; Biol. Pharm. Bull. 22, 1137 (1999)
- Inhibition of mitochondrial lipid peroxidation by Bakuchiol, a meroterpene from Psoralea corylifolia: H. Haraguchi, et al.; Planta Med. 66, 569 (2000)
- In vitro antimicrobial activities of bakuchiol against oral microorganisms: H. Katsura, et al.; Antimicrob. Agents Chemother. 45, 3009 (2001)
- Bakuchiol from Psoralea corylifolia inhibits the expression of inducible nitric oxide synthase gene via the inactivation of nuclear transcription factor-kappaB in RAW 264.7 macrophages: H.O. Pae, et al.; Int. Immunopharmacol. 1, 1849 (2001)
- Bakuchiol: a hepatoprotective compound of Psoralea corylifolia on tacrine-induced cytotoxicity in Hep G2 cells: H. Cho, et al.; Planta Med. 67, 750 (2001)
- Antioxidative components of Psoralea corylifolia (Leguminosae): H. Haraguchi, et al.; Phytother. Res. 16, 539 (2002)
- Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent: K. Bapat, et al.; Appl. Radiat. Isot. 62, 389 (2005)
- In vitro protein tyrosine phosphatase 1B inhibitory phenols from the seeds of Psoralea corylifolia: Y.C. Kim, et al.; Planta Med. 71, 87 (2005)
- Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts: E.J. Park, et al.; Eur. J. Pharmacol. 559, 115 (2007)